pI: 4.7357 |
Length (AA): 753 |
MW (Da): 85094 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127886)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G51310 | vacuolar protein sorting-associated protein 35C |
Arabidopsis thaliana | AT1G75850 | vacuolar protein sorting-associated protein 35B |
Arabidopsis thaliana | AT2G17790 | vacuolar protein sorting-associated protein 35A |
Babesia bovis | BBOV_IV009740 | vacuolar protein sorting-associated protein 35, putative |
Brugia malayi | Bm1_44045 | Vacuolar protein sorting 35 |
Candida albicans | CaO19.14164 | retrieval of vacuolar sorting receptor |
Candida albicans | CaO19.6875 | retrieval of vacuolar sorting receptor |
Caenorhabditis elegans | CELE_F59G1.3 | Protein VPS-35 |
Cryptosporidium hominis | Chro.40270 | vacuolar sorting protein 35 |
Cryptosporidium parvum | cgd4_2390 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0293218 | vacuolar sorting protein 35 |
Drosophila melanogaster | Dmel_CG5625 | Vacuolar protein sorting 35 |
Echinococcus granulosus | EgrG_000083200 | vacuolar protein sorting 35 |
Entamoeba histolytica | EHI_086580 | vacuolar protein sorting-associated protein 35 , putative |
Entamoeba histolytica | EHI_041950 | vacuolar protein sorting-associated protein 35 , putative |
Entamoeba histolytica | EHI_002990 | vacuolar protein sorting-associated protein 35 , putative |
Echinococcus multilocularis | EmuJ_000083200 | vacuolar protein sorting 35 |
Homo sapiens | 55737 | vacuolar protein sorting 35 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.21.0530 | vacuolar sorting-associated-like protein |
Leishmania donovani | LdBPK_210530.1 | vacuolar sorting-associated-like protein |
Leishmania infantum | LinJ.21.0530 | vacuolar sorting-associated-like protein |
Leishmania major | LmjF.21.0470 | vacuolar sorting-associated-like protein |
Leishmania mexicana | LmxM.21.0470 | vacuolar sorting-associated-like protein |
Loa Loa (eye worm) | LOAG_04650 | vacuolar protein sorting 35 |
Mus musculus | ENSMUSG00000031696 | vacuolar protein sorting 35 |
Neospora caninum | NCLIV_017680 | hypothetical protein |
Oryza sativa | 4334459 | Os03g0801600 |
Plasmodium berghei | PBANKA_0937100 | vacuolar protein sorting-associated protein 35, putative |
Plasmodium falciparum | PF3D7_1110500 | vacuolar protein sorting-associated protein 35, putative |
Plasmodium knowlesi | PKNH_0908200 | vacuolar protein sorting-associated protein 35, putative |
Plasmodium vivax | PVX_091175 | vacuolar protein sorting-associated protein 35, putative |
Plasmodium yoelii | PY01746 | vacuolar protein sorting 35-related |
Saccharomyces cerevisiae | YJL154C | Vps35p |
Schistosoma japonicum | Sjp_0025740 | Vacuolar protein sorting-associated protein 35, putative |
Schistosoma mansoni | Smp_173330 | vacuolar sorting protein |
Schmidtea mediterranea | mk4.001986.07 | Vacuolar protein sorting-associated protein 35 |
Schmidtea mediterranea | mk4.001986.06 | Vacuolar protein sorting-associated protein 35 |
Schmidtea mediterranea | mk4.002290.02 | Vacuolar protein sorting-associated protein 35 |
Schmidtea mediterranea | mk4.001986.08 | Vacuolar protein sorting-associated protein 35 |
Trypanosoma brucei gambiense | Tbg972.10.2750 | vacuolar protein sorting-associated protein 35, putative |
Trypanosoma brucei | Tb927.10.2270 | vacuolar protein sorting-associated protein 35, putative |
Trypanosoma congolense | TcIL3000_10_1880 | vacuolar protein sorting-associated protein 35, putative |
Trypanosoma cruzi | TcCLB.511367.170 | vacuolar protein sorting-associated protein 35, putative |
Toxoplasma gondii | TGME49_242660 | vacuolar sorting protein 35, putative |
Theileria parva | TP01_0794 | vacuolar sorting protein 35, putative |
Trichomonas vaginalis | TVAG_198400 | vacuolar sorting protein, putative |
Trichomonas vaginalis | TVAG_216890 | vacuolar sorting protein, putative |
Trichomonas vaginalis | TVAG_468000 | vacuolar sorting protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.2270 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.2270 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.2270 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.2270 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F59G1.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0937100 | Plasmodium berghei | Essential | plasmo |
TGME49_242660 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.